California Life Sciences (CLS) and Women in Bio (WIB) announced a new partnership to offer a premier program for emerging life sciences companies founded or co-founded by women this February.
The WIB-FAST Advisory Program, supported by Cooley LLP will launch in May with the following five women-led startups who are developing innovative and transformational therapeutic, diagnostic or device technologies to improve human health:
In the weeks leading up to the BIO International Convention, the founders will receive customized commercialization advising from a team of experts to assist them in different areas like positioning for capital (Angel, Seed or Series A), input on business strategy, and legal or scientific strategy. Each will present in the WIB-FAST track at Startup Stadium on June 14 at the BIO International Convention in San Diego—along with three FAST Alumni and WIB members–Nano PharmaSolutions, Navega Therapeutics and OncoXome. This is an exceptional opportunity to access key members of the investment community, venture philanthropy groups, strategic partners, and non-dilutive capital at the world’s largest biotechnology event.
About Women In Bio
Founded in 2002 to support all women employed in the field of life sciences from the classroom to the boardroom, Women In Bio (WIB) is a multifaceted organization with 14 chapters across North America and Montreal. It offers an array of professional educational programs, peer to peer learning, mentoring and networking opportunities, and is the only organization for women that integrates all career levels and life sciences fields. WIB is funded by sponsors and partners dedicated to supporting women of all ages in their lifelong journey in the life sciences and beyond. Please visit https://www.womeninbio.org.
